Results 201 to 210 of about 65,592 (243)

Severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma. [PDF]

GMS Ophthalmol Cases
Asensio-Sánchez VM.
europepmc   +1 more source

Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database. [PDF]

In Vivo
Masago S, Kotake K, Yamaoka K, Yorifuji K, Shimizu T.   +4 more
europepmc   +1 more source

Nivolumab plus ipilimumab versus lenvatinib or sorafenib for US and Chinese patients with unresectable hepatocellular carcinoma: a cost-effectiveness analysis. [PDF]

Front Public Health
Wu Q, Qin Y, Li Q.
europepmc   +1 more source

Adverse Events and Toxicity of Systemic Treatments for Uveal Melanoma: A Systematic Review. [PDF]

Cancers (Basel)
Lanzafame K, Blanco G, Paratore S, Maratta MG, Russo A, Asero S, Ursino MG, Marino P, Bordonaro R.   +8 more
europepmc   +1 more source

The cost-effectiveness analysis of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair deficient advanced colorectal cancer. [PDF]

Sci Rep
Yang P, Pei Z, Zhou Y, Pei H.
europepmc   +1 more source

Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study. [PDF]

Immunother Adv
Kennedy OJ, Lee R, Blackhall F, Choudhury A, Metcalf R, Waddell T, Lorigan P.   +6 more
europepmc   +1 more source

Cardiac adverse events associated with dual immune checkpoint inhibitors: a pharmacovigilance analysis from the FDA adverse event reporting system. [PDF]

Eur Heart J Cardiovasc Pharmacother
Xia H, Shi L, Luo S, Sun Z, Quan M, Xiao H, Chen Y, Lin J.   +7 more
europepmc   +1 more source

Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung). [PDF]

ESMO Open
He K, Forde PM, Govindan R, Santoro A, Gettinger S, Borghaei H, Spira A, Chu Q, Zinner R, Schoenfeld AJ, Camidge DR, Spigel DR, Gurpide A, Juergens RA, Laurie SA, Cerra M, Spires T, Greenawalt DM, Rapoport I, Gainor JF.   +19 more
europepmc   +1 more source